Isoprostanes: an emerging role in vascular physiology and disease?
- 31 March 2004
- journal article
- review article
- Published by Elsevier in Chemistry and Physics of Lipids
- Vol. 128 (1-2) , 75-83
- https://doi.org/10.1016/j.chemphyslip.2003.10.006
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Improved endothelial function by the thromboxane a2receptor antagonist s 18886 in patients with coronary artery disease treated with aspirinJournal of the American College of Cardiology, 2003
- Selective Neuromicrovascular Endothelial Cell Death by 8-Iso-Prostaglandin F 2αStroke, 2003
- Lipid Peroxidation Is Not Increased in Patients With Untreated Mild-to-Moderate HypertensionHypertension, 2003
- Receptors and signaling pathway underlying relaxations to isoprostanes in canine and porcine airway smooth muscleAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2002
- Increase of isoprostane 8-epi-PGF2 αafter restarting smokingProstaglandins, Leukotrienes & Essential Fatty Acids, 2001
- Oxidant Stress and Aspirin-Insensitive Thromboxane Biosynthesis in Severe Unstable AnginaCirculation, 2000
- The Thromboxane Receptor Antagonist S18886 but Not Aspirin Inhibits Atherogenesis in Apo E–Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Identification and Measurement of Endogenous β-Oxidation Metabolites of 8-epi-Prostaglandin F2αJournal of Biological Chemistry, 1999
- Metabolism of 8‐iso‐prostaglandin F2αFEBS Letters, 1998
- Plasma and Urinary 8-iso-Prostane as An Indicator of Lipid Peroxidation in Pre-Eclampsia and Normal PregnancyClinical Science, 1996